Arkolith/Insider Trading/JAZZ/Form 4

Carr Patricia

SVP, Chief Accounting OfficerJazz Pharmaceuticals plc (JAZZ) · full profile →Form 4 · filed Dec 9, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$798K
Net Open-Market Flow
-$798K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 5, 2025Sell(S)160$171.11$27K7K
Dec 5, 2025Sell(S)5K$171.20$770K7K
Dec 5, 2025Option exercise(M)5K$140.67$633K12K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 5, 2025Option exercise(M)5K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001784606-25-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML